Autologous blood predonation and perioperative use of erythropoïetine;Prédonation autologue et place de l'érythropoïé tine en phase périopératoire

Revue Medicale Suisse

Volumn 2, Issue 88, 2006, Pages 2662-2667

  Michaeli, Burkhard ^a   Ravussin, Patrick ^a   Chassot, Pierre Guy ^b  

^a CHCVs   (Switzerland)

^b LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ERYTHROPOIETIN;

ANEMIA; BLEEDING; BLOOD AUTOTRANSFUSION; BLOOD DONOR; ERYTHROCYTE; HUMAN; MORBIDITY; MORTALITY; PERIOPERATIVE PERIOD; POSTOPERATIVE COMPLICATION; PROGNOSIS; REVIEW;

ANEMIA; BLOOD LOSS, SURGICAL; BLOOD TRANSFUSION, AUTOLOGOUS; ERYTHROPOIETIN; HEMATOCRIT; HEMOGLOBINS; HUMANS; PERIOPERATIVE CARE;

EID: 33845903827     PISSN: 16609379     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (30)

1. Shander A, Knight K, Thurer R, et al. Prevalence and outcomes of anemia in surgery: A systematic review of the literature. Am J Med 2004;116(Suppl. 7A):58S-69.
2. Dunne JR, Malone D, Tracy JK, et al. Perioperative anemia: An independent risk factor for infection, mortality, and resource utilization in surgery. J Surg Res 2002;102:237-44.
3. Etchason J, Petz L, Keeler E, et al. The cost effectiveness of preoperative autologous blood donations. N Engl J Med 1995;332:719-24.
4. Jourdanet, D. De l'anémie des altitudes et de l'anémie en général dans ses rapports avec la pression de l'atmosphère. Paris: Ballière, 1863.
5. Carnot P, Deflandre C. Sur l'activité hémopoiétique du sérum au cours de la régénération du sang. Comptes Rendus de l'Academie des Sciences 1906;143:384-6.
6. Bonsdorff E, Jalavisto E. A humoral mechanism in anoxic erythrocytosis. Acta Physiol Scand 1948;16:150-70.
7. Lee-Huang S. Cloning and expression of human erythropoietin cDNA in Escherichia coli. Proc Natl Acad Sci USA 1984;81:2708-12.
8. Lin FK, Suggs S, Lin CH, et al. Cloning and expression of the human erythropoietin gene. Proc Natl Acad Sci USA 1985;82:7580-4.
9. Egrie JC, Browne JK. Development and characterization of novel erythropoiesis stimulating protein (NESP). Nephrol Dial Transplant 2001;16(Suppl. 3):3-13.
10. Macdougall IC. CERA (Continuous Erythropoietin Receptor Activator): A new erythropoiesis-stimulating agent for the treatment of anemia. Curr Hematol Rep 2005;4:436-40.
11. Watkins PC, Eddy R, Hoffman N, et al. Regional assignment of the erythropoietin gene to human chromosome region 7pter-q22. Cytogenet Cell Genet 1986;42:214-8.
12. Fisher JW. Erythropoietin: Physiology and pharmacology update. Exp Biol Med (Maywood) 2003;228:1-14.
13. Ueno M, Brookins J, Beckman B, et al. A1 and A2 adenosine receptor regulation of erythropoietin production. Life Sci 1988;43:229-37.
14. Wickrema A, Krantz SB, Winkelmann JC, et al. Differentiation and erythropoietin receptor gene expression in human erythroid progenitor cells. Blood 1992;80:1940-9.
15. Lacombe C, Mayeux P. The molecular biology of erythropoietin. Nephrol Dial Transplant 1999;14(Suppl 2):22-8.
16. Ng T, Marx G, Littlewood T, et al. Recombinant erythropoietin in clinical practice. Postgrad Med J 2003;79:367-76.
17. Eprex. Information professionnelle du Compendium Suisse des Médicaments. Janssen-Cilag, 2001.
18. Practice guidelines for perioperative blood transfusion and adjuvant therapies: An updated report by the American Society of Anesthesiologists Task Force on Perioperative Blood Transfusion and Adjuvant Therapies. Anesthesiology 2006;105:198-208.
19. Goodnough LT, Rudnick S, Price TH, et al. Increased preoperative collection of autologous blood with recombinant human erythropoietin therapy. N Engl J Med 1989;321:1163-8.
20. Laupacis A, Fergusson D. Erythropoietin to minimize perioperative blood transfusion: A systematic review of randomized trials. The International Study of Perioperative Transfusion (ISPOT) Investigators. Transfus Med 1998;8:309-17.
21. Couvret C, Laffon M, Baud A, et al. A restrictive use of both autologous donation and recombinant human erythropoietin is an efficient policy for primary total hip or knee arthroplasty. Anesth Analg 2004;99:262-71.
22. Weber EW, Slappendel R, Hemon Y, et al. Effects of epoetin alfa on blood transfusions and postoperative recovery in orthopaedic surgery: The European Epoetin Alfa Surgery Trial (EEST). Eur J Anaesthesiol 2005;22:249-57.
23. Effectiveness of perioperative recombinant human erythropoietin in elective hip replacement. Canadian Orthopedic Perioperative Erythropoietin Study Group. Lancet 1993;341:1227-32.
24. Faris PM, Ritter MA, Abels RI. The effects of recombinant human erythropoietin on perioperative transfusion requirements in patients having a major orthopaedic operation. The American Erythropoietin Study Group. J Bone Joint Surg Am 1996;78:62-72.
25. Lee JH, Lee SH, Oh JH. Minimal effective dosage of recombinant human erythropoietin in spinal surgery. Clin Orthop Relat Res 2003;412:71-6.
26. Crosby E. Perioperative use of erythropoietin. Am J Ther 2002;9:371-6.
27. Goodnough LT. The role of iron in erythropoiesis in the absence and presence of erythropoietin therapy. Nephrol Dial Transplant 2002;17(Suppl. 5):14-8.
28. Coyle D, Lee KM, Fergusson DA, et al. Economic analysis of erythropoietin use in orthopaedic surgery. Transfus Med 1999;9:21-30.
29. Coyle D, Lee KM, Fergusson DA, et al. Cost effectiveness of epoetin-alpha to augment preoperative autologous blood donation in elective cardiac surgery. Pharmacoeconomics 2000;18:161-71.
30. Goodnough LT, Shander A, Spivak JL, et al. Detection, evaluation, and management of anemia in the elective surgical patient. Anesth Analg 2005;101:1858-61.